Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence and the length of time it took to kill its victims, but these forms of plague ultimately died out.
A study by researchers at McMaster University and France’s Institut Pasteur, published in the journal Science, addresses some fundamental questions related to pandemics: how do they enter human populations, cause immense sickness, and evolve different levels of virulence to persist in populations?
The Black Death remains the single deadliest pandemic in recorded human history, killing an estimated 30–50% of the populations of Europe, Western Asia and Africa as it moved through those regions. Appearing in the 14th century, it re-emerged in waves over more than 500 years, persisting until 1840.
The Black Death was caused by the same bacteria which caused the Plague of Justinian, the first plague pandemic which had broken out in the mid-500s. The third plague pandemic began in China in 1855 and continues today. Its deadly effects are now more controlled by antibiotics but are still felt in regions like Madagascar and the Democratic Republic of Congo, where cases are regularly reported.
“This is one of the first research studies to directly examine changes in an ancient pathogen, one we still see today, in an attempt to understand what drives the virulence, persistence and/or eventual extinction of pandemics,” says Hendrik Poinar, co-senior author of the study, director of the McMaster Ancient DNA Center and holder of the Michael G. DeGroote Chair in Genetic Anthropology.
Strains of the Justinian plague became extinct after 300 years of ravaging European and Middle Eastern populations. Strains of the second pandemic emerged from infected rodent populations, causing the Black Death, before breaking into two major lineages. One of these two lineages is the ancestor of all present-day strains. The other re-emerged over centuries in Europe and ultimately went extinct by the early 19th century.
Using hundreds of samples from ancient and modern plague victims, the team screened for a gene known as pla, a high copy component of Y. pestis which helps it move through the immune system undetected to the lymph nodes before spreading to the rest of the body.
An extensive genetic analysis revealed that its copy number, or total number of pla genes found in the bacterium, had decreased in later outbreaks of the disease, which in turn decreased its mortality by 20% and increased the length of its infection, meaning the hosts lived longer before they died. These studies were performed in mice models of bubonic plague.
Conversely, when the pla gene was in its original, high copy number, the disease was much more virulent and killed each of its hosts and did so much quicker.

The scientists also identified a striking similarity between the trajectories of modern and ancient strains, which independently evolved similar reductions in pla in the later stages of the first and second pandemic, and so far, in three samples from the third pandemic, found in Vietnam today.
In both the Justinian and Black Death plagues, the evolutionary change occurred approximately 100 years after the first outbreaks. Scientists propose that when the gene copy number dropped and the infected rats lived longer, they could spread infection farther, ensuring the reproductive success of the pathogen.
“The reduction of pla may reflect the changing size and density of rodent and human populations,” explains Poinar. “It’s important to remember that the plague was an epidemic of rats, which were the drivers of epidemics and pandemics. Humans were accidental victims.”
Black rats in cities likely acted as “amplification hosts” due to their high numbers and proximity to humans. Because black rats are highly susceptible to Y. pestis, the pathogen needed rat populations to stay high enough to supply new hosts for Y. pestis to persist and allow the pandemic cycle to continue.
However, the pla-reduced strains eventually went extinct, likely reflecting another shift in the host-pathogen relationship within their environment.
When the researchers searched for signs of depletion in a large set of samples of the third pandemic preserved in a collection at the Institut Pasteur, they found three contemporary strains with pla depletion.
“Thanks to our international collaborators who monitor local epidemics of plague worldwide, we were able to find the unique bacterial samples used for this project, akin to finding three rare needles in a haystack,” says Javier Pizarro-Cerdá, co-senior author of the work, director of the Yersinia Research Unit and of the WHO Collaborating Center for Plague at the Institut Pasteur.
The institute houses one of the world’s richest collections of modern Y. pestis isolates, adds Guillem Mas Fiol, co-lead author of the study and postdoctoral researcher supervised by Pizarro-Cerdá.
“One of the most interesting aspects of our research was the possibility to explore a feature first observed in extinct plague strains, that could, for the first time, be experimentally tested in living contemporary bacterial strains,” he says.
“Although our research sheds light on an interesting pattern in the evolutionary history of plague, the majority of strains which continue to circulate today in Africa, South America and India are the more virulent ones, the ones that were previously responsible for massive mortality,” says Ravneet Sidhu, co-lead author of the study, and Ph.D. candidate at the McMaster Ancient DNA Center.
More information: Ravneet Kaur Sidhu et al, Attenuation of virulence in Yersinia pestis across three plague pandemics, Science (2025). DOI: 10.1126/science.adt3880. www.science.org/doi/10.1126/science.adt3880
Journal information: Science
News
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]















